Persons with dispensed medicines; origin
| Sex | Age | Origin | Medicine group (ATC) | Periods | Persons with medicines, relative (%) | Defined daily doses (DDD), relative (number per 1 000 persons) |
|---|---|---|---|---|---|---|
| Total male and female | Total age | Total | A02 Drugs for acid related disorders | 2022* | 12.48 | 45,198 |
| Total male and female | Total age | Total | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Total | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Total | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Total | L02A Hormones and related agents | 2022* | 0.22 | 648 |
| Total male and female | Total age | Total | L02B Hormone antagonists/related agents | 2022* | 0.40 | 1,139 |
| Total male and female | Total age | Origin: born in the Netherlands | A02 Drugs for acid related disorders | 2022* | 12.78 | 46,484 |
| Total male and female | Total age | Origin: born in the Netherlands | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in the Netherlands | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in the Netherlands | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in the Netherlands | L02A Hormones and related agents | 2022* | 0.23 | 690 |
| Total male and female | Total age | Origin: born in the Netherlands | L02B Hormone antagonists/related agents | 2022* | 0.42 | 1,208 |
| Total male and female | Total age | Origin: born in NL, parents in NL | A02 Drugs for acid related disorders | 2022* | 13.73 | 50,258 |
| Total male and female | Total age | Origin: born in NL, parents in NL | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL, parents in NL | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL, parents in NL | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL, parents in NL | L02A Hormones and related agents | 2022* | 0.24 | 740 |
| Total male and female | Total age | Origin: born in NL, parents in NL | L02B Hormone antagonists/related agents | 2022* | 0.45 | 1,304 |
| Total male and female | Total age | Origin: born in NL, parent(s) abroad | A02 Drugs for acid related disorders | 2022* | 6.76 | 22,642 |
| Total male and female | Total age | Origin: born in NL, parent(s) abroad | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL, parent(s) abroad | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL, parent(s) abroad | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL, parent(s) abroad | L02A Hormones and related agents | 2022* | 0.13 | 376 |
| Total male and female | Total age | Origin: born in NL, parent(s) abroad | L02B Hormone antagonists/related agents | 2022* | 0.23 | 605 |
| Total male and female | Total age | Origin: born in NL, 1 parent born in NL | A02 Drugs for acid related disorders | 2022* | 9.14 | 32,338 |
| Total male and female | Total age | Origin: born in NL, 1 parent born in NL | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL, 1 parent born in NL | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL, 1 parent born in NL | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL, 1 parent born in NL | L02A Hormones and related agents | 2022* | 0.18 | 517 |
| Total male and female | Total age | Origin: born in NL, 1 parent born in NL | L02B Hormone antagonists/related agents | 2022* | 0.30 | 860 |
| Total male and female | Total age | Origin: born in NL,2 parents born abroad | A02 Drugs for acid related disorders | 2022* | 3.87 | 10,847 |
| Total male and female | Total age | Origin: born in NL,2 parents born abroad | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL,2 parents born abroad | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL,2 parents born abroad | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born in NL,2 parents born abroad | L02A Hormones and related agents | 2022* | 0.08 | 204 |
| Total male and female | Total age | Origin: born in NL,2 parents born abroad | L02B Hormone antagonists/related agents | 2022* | 0.14 | 294 |
| Total male and female | Total age | Origin: born abroad | A02 Drugs for acid related disorders | 2022* | 10.91 | 38,492 |
| Total male and female | Total age | Origin: born abroad | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born abroad | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born abroad | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin: born abroad | L02A Hormones and related agents | 2022* | 0.16 | 428 |
| Total male and female | Total age | Origin: born abroad | L02B Hormone antagonists/related agents | 2022* | 0.29 | 778 |
| Total male and female | Total age | Origin country: The Netherlands | A02 Drugs for acid related disorders | 2022* | 13.73 | 50,258 |
| Total male and female | Total age | Origin country: The Netherlands | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: The Netherlands | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: The Netherlands | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: The Netherlands | L02A Hormones and related agents | 2022* | 0.24 | 740 |
| Total male and female | Total age | Origin country: The Netherlands | L02B Hormone antagonists/related agents | 2022* | 0.45 | 1,304 |
| Total male and female | Total age | Origin country: abroad | A02 Drugs for acid related disorders | 2022* | 9.18 | 31,899 |
| Total male and female | Total age | Origin country: abroad | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: abroad | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: abroad | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: abroad | L02A Hormones and related agents | 2022* | 0.15 | 406 |
| Total male and female | Total age | Origin country: abroad | L02B Hormone antagonists/related agents | 2022* | 0.26 | 706 |
| Total male and female | Total age | Origin country: Europe (excl. NL) | A02 Drugs for acid related disorders | 2022* | 8.48 | 29,573 |
| Total male and female | Total age | Origin country: Europe (excl. NL) | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Europe (excl. NL) | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Europe (excl. NL) | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Europe (excl. NL) | L02A Hormones and related agents | 2022* | 0.15 | 421 |
| Total male and female | Total age | Origin country: Europe (excl. NL) | L02B Hormone antagonists/related agents | 2022* | 0.28 | 806 |
| Total male and female | Total age | Origin country: outside Europe | A02 Drugs for acid related disorders | 2022* | 9.55 | 33,121 |
| Total male and female | Total age | Origin country: outside Europe | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: outside Europe | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: outside Europe | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: outside Europe | L02A Hormones and related agents | 2022* | 0.15 | 399 |
| Total male and female | Total age | Origin country: outside Europe | L02B Hormone antagonists/related agents | 2022* | 0.25 | 653 |
| Total male and female | Total age | Origin country: Morocco | A02 Drugs for acid related disorders | 2022* | 11.73 | 42,463 |
| Total male and female | Total age | Origin country: Morocco | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Morocco | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Morocco | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Morocco | L02A Hormones and related agents | 2022* | 0.12 | 317 |
| Total male and female | Total age | Origin country: Morocco | L02B Hormone antagonists/related agents | 2022* | 0.20 | 520 |
| Total male and female | Total age | Origin country: Turkey | A02 Drugs for acid related disorders | 2022* | 13.41 | 49,880 |
| Total male and female | Total age | Origin country: Turkey | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Turkey | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Turkey | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Turkey | L02A Hormones and related agents | 2022* | 0.11 | 304 |
| Total male and female | Total age | Origin country: Turkey | L02B Hormone antagonists/related agents | 2022* | 0.23 | 596 |
| Total male and female | Total age | Origin country: Suriname | A02 Drugs for acid related disorders | 2022* | 12.53 | 44,496 |
| Total male and female | Total age | Origin country: Suriname | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Suriname | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Suriname | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Suriname | L02A Hormones and related agents | 2022* | 0.21 | 523 |
| Total male and female | Total age | Origin country: Suriname | L02B Hormone antagonists/related agents | 2022* | 0.29 | 806 |
| Total male and female | Total age | Origin country: Dutch Caribbean | A02 Drugs for acid related disorders | 2022* | 7.24 | 23,765 |
| Total male and female | Total age | Origin country: Dutch Caribbean | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Dutch Caribbean | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Dutch Caribbean | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Dutch Caribbean | L02A Hormones and related agents | 2022* | 0.22 | 574 |
| Total male and female | Total age | Origin country: Dutch Caribbean | L02B Hormone antagonists/related agents | 2022* | 0.26 | 679 |
| Total male and female | Total age | Origin country: Indonesia | A02 Drugs for acid related disorders | 2022* | 14.18 | 49,634 |
| Total male and female | Total age | Origin country: Indonesia | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Indonesia | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Indonesia | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Indonesia | L02A Hormones and related agents | 2022* | 0.26 | 783 |
| Total male and female | Total age | Origin country: Indonesia | L02B Hormone antagonists/related agents | 2022* | 0.55 | 1,649 |
| Total male and female | Total age | Origin country: Outside Europe (exc. 5.. | A02 Drugs for acid related disorders | 2022* | 6.15 | 19,556 |
| Total male and female | Total age | Origin country: Outside Europe (exc. 5.. | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Outside Europe (exc. 5.. | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | Total age | Origin country: Outside Europe (exc. 5.. | L01D Cytoox.antibiotics/related substan | 2022* | 0.00 | 0 |
| Source: CBS. | ||||||
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, origin, age and sex.
Data available from 2020.
Status of the figures:
Figures for 2022 are provisional.
Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.
When will new figures be published?
New figures will be published in the last quarter of 2024.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.
- Defined daily doses (DDD), relative
- Defined Daily Dose (DDD) is de door de WHO vastgestelde gemiddelde dagelijkse dosis van een geneesmiddel, wanneer het geneesmiddel wordt ingezet voor de hoofdindicatie, bij een onderhoudsbehandeling voor volwassenen. Deze definitie maakt het mogelijk om het gebruik van verschillende toedieningsvormen en verschillende middelen met elkaar te vergelijken.
WHO: World Health Organisation, Wereldgezondheidsorganisatie